Trillions of bugs known as gut microbes live symbiotically in the human gut. They play a key role in many of the processes that take place inside the body. Different people have different types of gut microbes living inside them and abnormalities in some types have recently been linked to diseases such as diabetes and obesity.
The authors of the Perspective argue that targeting gut microbes with new drug therapies, rather than concentrating on the mechanisms in the human body which are the current focus of most drug development programmes, could provide an array of uncharted possibilities for fighting disease. Much research is still needed to untangle the precise role played by each different type of bug.
Professor Jeremy Nicholson, one of the authors of the Perspective from the Department of Biomolecular Medicine at Imperial College London, explained: "It's only recently that we've discovered the huge influence that bugs in the gut have on people's health. The exciting thing about this is that it should be easier to create drugs that can change the bugs than it is to re-engineer human cells and signalling pathways inside the body. Also, if we're not interfering with the body's pathways, these drugs should have less toxic side-effects."
Research has already shown that the makeup of an individual's gut microbes is affected by their diet and other environmental factors. A recent study led by scientists from Imperial College showed that it is possible to alter the makeup of bugs in a mouse's gut, affecting their metabolism, using probiotics.
"We already know that external factors such as altering your diet can change the makeup of the bugs in your gut, so these kinds of therapies will mean a more holistic approach to medicine, looking not just at pharmaceutical treatments but also at lifestyle and nutrition. I think that in ten years' time it will be normal for scientists to take gut bugs into consideration when they are creating new medicines," added Professor Nicholson.
Laura Gallagher | alfa
Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University
The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.
Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
02.12.2016 | Medical Engineering
02.12.2016 | Agricultural and Forestry Science
02.12.2016 | Physics and Astronomy